Join Stevanato Group at the 16th American Drug Delivery & Formulation Summit, bringing together pharmaceutical, biotechnology, drug delivery, and device-development professionals for two days of technical presentations, case studies, and networking.

As part of the conference program, Stevanato Group will welcome Aaron May, Associate Director, Drug Product MSAT at TG Therapeutics, for the presentation:

<<Key Considerations for Transition to Subcutaneous Administration of a High-Concentration Monoclonal Antibody Formulation>>

Tuesday, September 15 – 12:20 pm – 12:50 pm – Room 4

The summit will provide a valuable forum to discuss current challenges, share technical insights, and connect with leaders across the pharmaceutical and biotechnology industries.

View the full agenda and register here: https://ddfsummit.com/live/en/page/home

We look forward to seeing you in Boston.